1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Iris Acquisition Corp

Iris Acquisition Corp

IRAAU
Iris Acquisition CorpUS flagNASDAQ Global Market
10.70
USD
+8.69
- -
81.01MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
4
10
-1
-3
-3
Effective Tax Rate (%)
- -
- -
5
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Working Capital
- -
-1
-3
-5
-8
-8
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
- -
255
1
-11
-16
-16
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
3.43
7.97
- -
- -
- -
Return on Common Equity (%)
- -
- -
8.01
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
4
5
5
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
- -
- -
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
8
9
Payables & Accruals
3
3
3
ST Debt
4
5
5
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
48.42%
Free Cash Flow
- -
- -
48.69%
Net Income, GAAP
- -
- -
136.85%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Sumit Mehta
Sector
Financial Services
Industry
Shell Companies
Address
2700 19th Street San Francisco CA United States of America 94110
IPO Date
Mar 5, 2021
CIK
0001831874
Website
tribecapitalgrowthcorp.com
Similar Companies
Authentic Equity Acquisition Corp. (AEAC)
Northern Star Investment Corp. III (NSTC-WT)
Ribbon Acquisition Corp (RIBB)
Embrace Change Acquisition Corp. (EMCGW)
New Vista Acquisition Corp (NVSAU)
Accretion Acquisition Corp. (ENER)
Business
Iris Acquisition Corp (IRAAU) operates as a blank-check company, or special purpose acquisition company (SPAC), with no significant ongoing operations and a focus on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with one or more businesses, primarily targeting opportunities in the biopharmaceutical sector. The company, formerly known as Tribe Capital Growth Corp I, changed its name in July 2022; it was incorporated in 2020 and maintains its headquarters in George Town, Cayman Islands. In a major development, Iris completed a reverse merger with Liminatus Pharma, LLC on April 30, 2025, resulting in the formation of Liminatus Pharma, Inc. (Nasdaq: LIMN), a pre-clinical stage biopharmaceutical company developing novel immune-modulating cancer therapies, including its lead candidate IBA101, a next-generation humanized anti-CD47 monoclonal antibody checkpoint inhibitor targeted at advanced solid tumors such as non-small cell lung cancer; the combined entity's common stock and warrants began trading on Nasdaq under LIMN and LIMNW on May 1, 2025, following stockholder approval on March 4, 2025, and Nasdaq delisting of Iris securities effective shortly thereafter with continued OTC trading.